Mollereau C - Search Results

1

Tissue distribution of the opioid receptor-like (ORL1) receptor.

Mollereau C, Mouledous L. Mollereau C, et al. Peptides. 2000 Jul;21(7):907-17. doi: 10.1016/s0196-9781(00)00227-8. Peptides. 2000. PMID: 10998524 Review.

2

Pharmacological characterization of the mouse NPFF2 receptor.

Talmont F, Moulédous L, Piedra-Garcia L, Schmitt M, Bihel F, Bourguignon JJ, Zajac JM, Mollereau C. Talmont F, et al. Among authors: mollereau c. Peptides. 2010 Feb;31(2):215-20. doi: 10.1016/j.peptides.2009.11.020. Epub 2009 Nov 26. Peptides. 2010. PMID: 19944730

3

Solubilization and reconstitution of the mu-opioid receptor expressed in human neuronal SH-SY5Y and CHO cells.

Talmont F, Moulédous L, Mollereau C, Zajac JM. Talmont F, et al. Among authors: mollereau c. Peptides. 2014 May;55:79-84. doi: 10.1016/j.peptides.2014.02.009. Epub 2014 Feb 25. Peptides. 2014. PMID: 24582609

4

Pharmacological insight into the activation of the human neuropeptide FF2 receptor.

Talmont F, Veneziano R, Dietrich G, Moulédous L, Mollereau C, Zajac JM. Talmont F, et al. Among authors: mollereau c. Peptides. 2020 Dec;134:170406. doi: 10.1016/j.peptides.2020.170406. Epub 2020 Sep 10. Peptides. 2020. PMID: 32920044

5

Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A.

Mollereau C, Mouledous L, Lapalu S, Cambois G, Moisand C, Butour JL, Meunier JC. Mollereau C, et al. Mol Pharmacol. 1999 Feb;55(2):324-31. doi: 10.1124/mol.55.2.324. Mol Pharmacol. 1999. PMID: 9927625

6

Functional inactivation of the nociceptin receptor by alanine substitution of glutamine 286 at the C terminus of transmembrane segment VI: evidence from a site-directed mutagenesis study of the ORL1 receptor transmembrane-binding domain.

Mouledous L, Topham CM, Moisand C, Mollereau C, Meunier JC. Mouledous L, et al. Among authors: mollereau c. Mol Pharmacol. 2000 Mar;57(3):495-502. doi: 10.1124/mol.57.3.495. Mol Pharmacol. 2000. PMID: 10692489

7

Neuropeptide FF-sensitive confinement of mu opioid receptor does not involve lipid rafts in SH-SY5Y cells.

Moulédous L, Merker S, Neasta J, Roux B, Zajac JM, Mollereau C. Moulédous L, et al. Among authors: mollereau c. Biochem Biophys Res Commun. 2008 Aug 15;373(1):80-4. doi: 10.1016/j.bbrc.2008.05.174. Epub 2008 Jun 9. Biochem Biophys Res Commun. 2008. PMID: 18544342 Free article.

8

Modulation by neuropeptide FF of the interaction of mu-opioid (MOP) receptor with G-proteins.

Kersanté F, Moulédous L, Zajac JM, Mollereau C. Kersanté F, et al. Among authors: mollereau c. Neurochem Int. 2010 May-Jun;56(6-7):768-73. doi: 10.1016/j.neuint.2010.02.014. Epub 2010 Mar 6. Neurochem Int. 2010. PMID: 20211672

9

Opioid-modulating properties of the neuropeptide FF system.

Moulédous L, Mollereau C, Zajac JM. Moulédous L, et al. Among authors: mollereau c. Biofactors. 2010 Nov-Dec;36(6):423-9. doi: 10.1002/biof.116. Epub 2010 Aug 27. Biofactors. 2010. PMID: 20803521 Review.

10

GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.

Moulédous L, Froment C, Dauvillier S, Burlet-Schiltz O, Zajac JM, Mollereau C. Moulédous L, et al. Among authors: mollereau c. J Biol Chem. 2012 Apr 13;287(16):12736-49. doi: 10.1074/jbc.M111.314617. Epub 2012 Feb 28. J Biol Chem. 2012. PMID: 22375000 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page